Salius Pharma Pvt Ltd

Ketorolac Tromethamine is a potent non-steroidal anti-inflammatory drug (NSAID) used primarily for the short-term management of moderate to severe pain. As a tromethamine salt of Ketorolac, it exhibits improved solubility and bioavailability, making it suitable for various formulations including injectables, tablets, ophthalmic solutions, and nasal sprays. The compound works by inhibiting prostaglandin synthesis through COX enzyme inhibition, offering effective analgesic and anti-inflammatory benefits without opioid-related side effects.

Salius Pharma, a globally trusted supplier of high-quality pharmaceutical ingredients, offers Ketorolac Tromethamine API with a strong emphasis on quality, compliance, and regulatory readiness. Manufactured under GMP and ISO-certified conditions, Salius ensures that each batch of the API complies with USP/BP standards, and is backed by comprehensive regulatory documentation including DMF, CoA, MSDS, and stability data. Their global presence and export capabilities across Asia, Europe, Africa, and Latin America make them a preferred partner for pharmaceutical manufacturers seeking consistent quality and regulatory support.